Ganoderic Acid A (GAA) can potentially ameliorate inflammatory bowel disease by modulating the intestinal flora and enhancing AhR activity, which in turn promotes IL-22 production and improves intestinal barrier function (115). Here, AHR is linked to inflammatory bowel disease.